A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients With Symptomatic Osteoarthritis of the Knee.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hylan G-F 20 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 03 Apr 2015 Biomarkers information updated
- 25 Jan 2012 New trial record